{"id":652,"date":"2020-08-04T01:35:37","date_gmt":"2020-08-04T05:35:37","guid":{"rendered":"https:\/\/cib.udp.cl\/cms\/publicacion\/oral-administration-of-recombinant-neisseria-meningitidis-pora-genetically-fused-to-h-pylori-hpaa-antigen-increases-antibody-levels-in-mouse-serum-suggesting-that-pora-behaves-as-a-putative-adjuvant\/"},"modified":"2020-09-01T16:38:26","modified_gmt":"2020-09-01T20:38:26","slug":"oral-administration-of-recombinant-neisseria-meningitidis-pora-genetically-fused-to-h-pylori-hpaa-antigen-increases-antibody-levels-in-mouse-serum-suggesting-that-pora-behaves-as-a-putative-adjuvant","status":"publish","type":"publicacion","link":"https:\/\/cib.udp.cl\/en\/publicacion\/oral-administration-of-recombinant-neisseria-meningitidis-pora-genetically-fused-to-h-pylori-hpaa-antigen-increases-antibody-levels-in-mouse-serum-suggesting-that-pora-behaves-as-a-putative-adjuvant\/","title":{"rendered":"Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant"},"content":{"rendered":"","protected":false},"featured_media":887,"template":"","class_list":["post-652","publicacion","type-publicacion","status-publish","has-post-thumbnail","hentry","revista-human-vaccines-immunotherapeutics"],"acf":[],"_links":{"self":[{"href":"https:\/\/cib.udp.cl\/en\/wp-json\/wp\/v2\/publicacion\/652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cib.udp.cl\/en\/wp-json\/wp\/v2\/publicacion"}],"about":[{"href":"https:\/\/cib.udp.cl\/en\/wp-json\/wp\/v2\/types\/publicacion"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cib.udp.cl\/en\/wp-json\/wp\/v2\/media\/887"}],"wp:attachment":[{"href":"https:\/\/cib.udp.cl\/en\/wp-json\/wp\/v2\/media?parent=652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}